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Abstract: Graphene-related materials (GRMs) are widely used in various applications due to their
unique properties. A growing number of reports describe the impact of different carbon nanomaterials,
including graphene oxide (GO), reduced GO (rGO), and carbon nanotubes (CNT), on immune cells, but
there is still a very limited number of studies on graphene. In this work, we investigated the biological
responses of few layer graphene (FLG) on mouse macrophages (bone marrow derived macrophages,
BMDMs), which are part of the first line of defense in innate immunity. In particular, our paper
describes our findings of short-term FLG treatment in BMDMs with a focus on observing material
internalization and changes in general cell morphology. Subsequent investigation of cytotoxicity
parameters showed that increasing doses of FLG did not hamper the viability of cells and did not
trigger inflammatory responses. Basal level induced autophagic activity sufficed to maintain the
cellular homeostasis of FLG treated cells. Our results shed light on the impact of FLG on primary
macrophages and show that FLG does not elicit immunological responses leading to cell death.
Keywords: graphene; carbon nanomaterials; autophagy; primary immune cells; bone marrow
derived macrophages
1. Introduction
Isolated and characterized for the first time in 2004, graphene is an atomic monolayer of carbon
atoms arranged into a hexagonal graphitic structure [1,2]. Since then, graphene and graphene-related
materials (GRMs) have gained considerable attention in different fields and applications, especially
in the biomedical domain [3,4]. Due to their unique properties, GRMs have found uses in water
filtration systems, touch screens, medical sensors, energy storage capacitors and drug delivery [2].
Graphene research has in particular been significantly expanded to biomedical applications, which
include tissue engineering, molecular imaging, antibacterial papers as well as carriers for anticancer
drugs [5]. We recently highlighted why a careful characterization of GRMs is mandatory to understand
the relationship between the physicochemical properties and the biological effects of these materials [6].
In the overall safety assessment of 2D materials on health and environment, one of the essential aspects
is to look at the interaction of graphene and GRMs with immune cells and evaluate their responses.
Studies on the whole genome expression of human peripheral blood mononuclear cells (PBMCs)
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from healthy donors after exposure to small and large GO (graphene oxide) showed differential
expression of genes associated with different immunological pathways, while the viability of cells was
not significantly affected by both small and large GO [7]. This study showed how graphene materials of
different dimensions are able to regulate the immune response, looking at differential gene expression
and activation patterns of molecular expression.
Many studies on the biocompatibility of GRMs have been reported mainly on the mouse
macrophage cell line RAW 264.7. Wang et al. observed that RAW 264.7 cells incubated with GO
functionalized with polyethylene glycol (PEG) and polyethylenimine (PEI) were 90% viable at low
concentrations and that GO-PEG could trigger an inflammatory response eliciting IL-6 secretion [8].
In another study, rGO (reduced GO) microfibers inhibited cell proliferation without affecting the
viability of macrophages. Inflammatory cytokine secretion showed the polarization of cells to M2 type
macrophages as indicated by decreased TNF-α production and an increase in IL-6 cytokine secretion
after 48 h [9]. Recently, the autophagic pathway has been considered as a key process involved in cell
death and in survival mechanisms of immune cells exposed to nanomaterials. It has also been alluded
to in accounting for the eventual fate of cell internalized nanomaterials [10]. Autophagy is a conserved
intracellular process that delivers cytoplasmic contents to lysosomes for degradation based on the
formation of double-membrane autophagosomes [10]. Cells tend to regulate autophagy, which is
usually present at a basal level, but they also induce autophagy to break down parts of its own proteins
or organelles to stay alive under pathophysiological conditions [11]. Autophagy is frequently activated
in many immune cells, and nowadays it is widely studied to better understand the interaction of
nanomaterials with mammalian cells, and even with respect to whole organs [10]. Within the class of
GRMs, GO has been found to induce autophagy in cells such as macrophages and in the colon cancer cell
line CT26, simultaneously activating toll-like receptors TLR 4 and TLR 9 [12,13]. Similarly, CNTs (carbon
nanotubes) internalized by peritoneal macrophages induced autophagosome formation, decreased
autophagic degradation and lysosomal impairment [14]. As such, we attempted to investigate the
impact of this important cellular process on graphene material treatment in macrophages.
A certain number of studies on the potential biological effects of graphene materials have appeared
in recent years [4–6]. Within the different graphene materials, FLG (few-layer graphene) is gaining in
importance in fields like nanomedicine, thanks to its production in bulk quantities and its colloidal
properties in biological media [15]. Even fewer papers tackle the convoluted issue of material uptake,
which involves detailed and laborious procedures such as the gold standard method of transmission
electron microscopy (TEM) to track intracellular material. Other studies on cellular internalization
of FLG involved the preparation of radioactive labeled-sheets [16–18] but studying material uptake
remains a very challenging task.
Indeed, this was likely neglected in the past due to issues related to the dispersibility of graphene
in physiological media typically used in cell culture. Leon et al. were able to produce FLG by
mechanochemical exfoliation of graphite, which is well dispersible in cell culture media (CCM) [19].
Russier et al. demonstrated that FLG is able to selectively kill tumor cells from myelomonocytic
leukemia patients [20]. Recently, it has been reported that FLG can induce oxidative stress and
endoplasmic-mediated autophagy in RAW264.7 macrophages [21]. In primary T and B cells, in contrast,
our group has found that FLG does not impact viability and activation, nor autophagic activity [22].
It must be noted that various cells harbor different responses to FLG, and nanomaterials in
general, and it is therefore pertinent to conduct separate studies independently. To expand the studies
on other primary immune cells in particular, we decided to evaluate the effect of FLG on primary
macrophages, derived from mouse bone marrow cells, with respect to their immunological and
autophagic functions. For this purpose, we looked at the survival and activation of macrophages both
in terms of upregulation of surface markers and secretion of pro-inflammatory cytokines. The impact
of FLG on autophagic activity was also studied together with the internalization of the material within
the cells, using TEM. In summary, our results show that FLG was internalized mainly into phagosomes
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by bone marrow derived macrophages and neither affected cell viability and homeostasis, nor induced
inflammatory response.
2. Materials and Methods
2.1. Preparation of FLG
A mechanochemical exfoliation method using a ball milling technique in the presence of melamine
as the exfoliating agent was used to obtain FLG. A mixture of graphite and melamine was ball milled
at 100 rpm for 30 min and the resulting solid mixture was dispersed in water and briefly sonicated,
obtaining a dark suspension. Melamine was then washed away by dialysis, and some precipitate,
consisting in poorly exfoliated graphite, was eliminated from the liquid fraction after stabilization
for five days. The final FLG water dispersions were lyophilized and the final graphene powder
was characterized and used in the cell experiments following the dispersion in culture media [19].
The characterization of FLG by elemental analysis, TEM and Raman spectroscopy, was previously
published by Murera et al. [22]. Briefly, the lateral size of the nanomaterial ranges from 100 nm to
1600 nm, the Raman average spectrum of FLG is composed of the typical graphene Raman bands:
G peak, D peak, and 2D band, which are centered at ~1580 cm−1, ~1350 cm−1, and ~2680 cm−1,
respectively, and elemental analysis showed that the sample is mainly composed of carbon, with
a maximum of 0.93 ppm of melamine traces. The number of layers in FLG was acquired via an
established formula, which relates the different intensities of G and 2D bands of FLG and graphite,
respectively. According to this calculation, our FLG is composed of ~3 layers [23].
2.2. Isolation and Differentiation of Bone Marrow Cells to BMDMs
All experiments were carried out in conformity with the 2010/63/UE European animal bioethics
legislation (French decree #2013-118 – 1st February 2013) and were approved by the Regional
Ethics Committee of Strasbourg (CREMEAS) and by the French Ministry of Higher Education
and Research (APAFIS#3280-2015121815099907 v2). Bone marrow cells (BMCs) were isolated from
femurs from 9 to 18-week-old C57BI6/J mice. Femurs were trimmed at both ends and BMCs
were flushed out using RPMI 1640 medium supplemented with 10% FBS, 10 mM HEPES buffer
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 10 µg/mL gentamycin sulfate and 0.05 mM
β-mercaptoethanol (complete RPMI medium) into Petri dishes. After one wash with medium, bone
marrow cells were treated with ACK lysis buffer (154.4 mM ammonium chloride, 10 mM potassium
bicarbonate and 97.3µM EDTA tetrasodium salt) for 4 min to lyse red blood cells (RBCs). Cells were
then washed twice using RPMI 1640 supplemented medium. BMCs were dispersed in RPMI 1640
supplemented medium containing 30% L929-conditioned medium (i.e., supernatant from the culture
of M-CSF-producing L929 cells), seeded into Petri dishes and incubated at 37 ◦C in CO2 incubator for
3 days. Afterward, the old medium was removed and replenished with a new medium for the next
3–4 days. Cells were detached upon attaining confluence and used for further experiments.
2.3. Addition of FLG to BMDMs
In 24-well plates, 0.5 × 106 or 1 × 106 cells were added and allowed to adhere for 4 h or
overnight. Once the cells have adhered (confirmed by optical microscopy), they were washed once
with the RPMI-supplemented medium to remove non-adherent cells. An FLG stock solution of
100 µg/mL was prepared by dispersing pre-weighed FLG in RPMI-supplemented medium containing
30% L929-conditioned medium. Before adding the FLG to the cells, FLG was sonicated for 30–60 s at
intervals of 20 s in a water bath. The concentrations of FLG used were 3, 10, 30, and 100 µg/mL and the
incubation time was 24 h.
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2.4. Transmission Electron Microscopy (TEM)
For TEM imaging, BMDMs were cultured in 24-well plates as previously described at a density of
1 × 106 cells per well and allowed to adhere before exposure to 100 µg/mL FLG for 24 h along with
control untreated cells. After incubation, the cells were washed with cacodylate buffer twice and then
fixed in 2.5% glutaraldehyde in cacodylate buffer at 4 ◦C overnight. Following overnight fixation,
the cells were rinsed thrice with cacodylate buffer alone. Later, the cells were post-fixed with 0.5%
osmium tetroxide for 30 min at room temperature and were washed thrice by MilliQ water. Cells were
then dehydrated through a series of ethanol baths: 1 × 25% ethanol for 10 min, 1 × 50% ethanol for
15 min, 1 × 70% ethanol for 15 min, 1 × 95% ethanol for 10 min, and 3 × 100% ethanol for 15 min.
Following dehydration, the cells were soaked in a 1:1 ratio of 100% ethanol and Epon™ overnight at
4 ◦C. The next day, the cells were rinsed (2 × 4 h) with Epon™. After soaking, the final inclusion of
Epon™ into the cells was done by polymerizing Epon™ at 40 ◦C for 30 min then incubating at 60 ◦C
for 48 h. Afterward, the polymerized blocks were removed and sliced into ultrathin sections using a
diamond knife attached to an ultramicrotome cutter (Leica). The ultrathin sections were then collected
on copper grids coated with Butvar® B-98 and stained with 1% uranyl acetate for 30 min followed with
lead citrate staining for 2 min. Grids were then examined by TEM (Hitachi H600, Krefeld, Germany).
Control cells without FLG underwent the same procedure.
2.5. Flow Cytometer Analyses
Viability and activation of 24 h FLG-treated BMDMs were assessed using flow cytometry (Gallios,
Beckman Coulter, Villepinte, France). Control (untreated), FLG-treated and LPS (lipopolysaccharide of
E. coli 0111:B4, Sigma Aldrich, Darmstadt, Germany-treated cells were detached by washing once with
cold PBS and incubated with 2% fetal bovine serum (FBS) and 0.5 mM EDTA in PBS (FACS Buffer)
for 10 min at 37 ◦C. After incubation, the cells were detached from the plates by pipetting. Then they
were washed twice (with 2% FBS in PBS). After washing, the cells were stained with an antibody mix
at 4 ◦C for 20 min. The antibodies used were specific for CD11b (PerCP/Cy5.5 anti-mouse/human,
Clone M1/70, #101228 from Biolegend, San Diego, CA, USA), F4/80 (APC, anti-mouse, Clone BM8,
#123116 from Biolegend), F4/80 (PE anti-mouse, Clone BM8, #123110 from Biolegend), to identify
mouse macrophage populations. For the activation of BMDMs, antibodies specific for CD80 (FITC
Hamster anti-mouse, Clone 16-10A1, #553768, from BD Pharmingen) and CD86 (PE rat anti-mouse,
Clone GL1, #553692, from BD Pharmingen, Le Pont de Claix, France) were used. The viability of cells
was analyzed by staining with Fixable Viability Dye (FVD-eFluor 780, #65-0865-14, from eBioscience,
San Diego, CA, USA). After staining, cells were washed twice by centrifuging at 1700 rpm for 2 min.
Then cells were dispersed in FACS buffer and analyzed on the flow cytometer. The relevant controls
were set up as shown in Figure S1A,B.
2.6. ELISA
Secretion of the pro-inflammatory cytokines IL-6, IL-1β and TNF-α by macrophages left untreated,
LPS-treated or treated with different concentrations of FLG (i.e., 3, 10, 30, and 100 µg/mL), were
assayed using a double sandwich ELISA according to the manufacturer’s instructions. In short,
polyvinyl microtiter 96-well plates (Falcon) were coated overnight at 4 ◦C with 50 µL/well of purified
rat anti-mouse IL-6 (0.5 mg/mL, BD Pharmingen #554400), rabbit anti-mouse TNF-α (0.5 mg/mL, BD
Pharmingen #557516) and IL-1β (1 mg/mL, BD Biosciences, Le Pont de Claix, France), #51_26661E),
diluted in coating buffer (Carbonate/bicarbonate buffer 0.05 M, pH 9.6). After washing with PBS
containing 0.05% Tween (PBS-T), a saturation step was performed by adding RPMI complete medium
(100 µL/well) for 1 h at 37 ◦C. After washing with PBS-T three times, 50 µL of culture supernatants
from untreated, FLG-treated and LPS-treated macrophages were added in the respective wells for
2 h at 37 ◦C, along with mouse recombinant IL-6 (BD Pharmingen #554582,), recombinant TNF-α
(BD Pharmingen #554589) and recombinant IL-1β (BD opti EIA kit, #51_26666E,), individually as
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standards. The plates were then washed five times with PBS-T. The supernatant was spun down to
remove all FLG and cells, before the ELISA procedure. For secondary antibodies, biotin anti-mouse
IL-6 (0.5 mg/mL, BD Pharmingen #554402), biotin anti-mouse TNF-α (0.5 mg/mL, BD Pharmingen
#557432) and biotin anti-mouse IL-1β (1 mg/mL, BD Biosciences, #51_26662E) were incubated for 1 h
at room temperature. Then, the plates were washed five times with PBS-T, and an equal volume of
streptavidin conjugated to horseradish peroxidase (diluted 1/400) was added per well. After 30 min
of incubation at room temperature, the plates were washed with PBS-T and twice with MilliQ water.
The presence of cytokines in the tested supernatants was visualized by adding tetramethylbenzidine
(TMB) in the presence of H2O2. The resulting absorbance was measured at 450 nm after stopping the
reaction with 1 N HCl, after 15 min.
2.7. Western Blots
To evaluate autophagic activity, whole-cell proteins were extracted from macrophages treated
with low (10 µg/mL) and high (100 µg/mL) concentrations of FLG for 24 h along with untreated
and LPS-treated cells using Laemmli buffer (Tris-HCl 125 mM pH 6.8, 2% (w/v) sodium dodecyl
sulfate (SDS); 10% (v/v) glycerol; 5% (v/v) β-mercaptoethanol). Cell lysates were separated on a 4–20%
gradient gel (Biorad, Schiltigheim, France) and then transferred onto a polyvinylidene difluoride
(PVDF) membrane. Cell membranes were blocked with PBS containing 0.1% (v/v) Tween 20 (PBS-T)
and 5% (w/w) non-fat dry milk for 1 h and incubated 50 min at 4 ◦C with a 1 µg/mL anti-LC3 antibody
in PBS-T containing 5% non-fat dry milk. The antibodies used for western immunoblotting were
specific for the LC3 autophagic marker (MBL, clone 51-11, #M115-3) and the β-actin loading control
(C4 mouse monoclonal antibody, Santa Cruz Biotechnology, #47778). After washing with PBS-T,
the membranes were incubated for 30 min at room temperature with goat anti-mouse IgG antibody
(Southern Biotech, Birmingham, Alabama, #1030-05) conjugated to horseradish peroxidase (HRP).
The signal was detected using enhanced chemiluminescence detection reagents (Immobilon Western,
Merck Millipore, Darmstadt, Germany, #WBKLS0500) and visualized on radiographic film in a Kodak
processor (#M35-M X-OMAT, Rochester, NY, USA).
2.8. Statistical Analysis
The experiments were conducted at least three times. The data were processed by GraphPad
Prism 6. The results are expressed as mean ± standard deviations (SD). The mean values of each
treated group were statistically compared with untreated samples using One-way ANOVA followed
by Bonferroni’s test, with p < 0.05 considered as statistically significant.
3. Results and Discussion
3.1. Internalization of FLG by BMDMs
We initially observed the internalization of FLG within BMDMs, hence we compared the TEM
images of BMDMs interacting with high dose (100 µg/mL) FLG for 24 h with untreated control
cells. The TEM images (Figure 1) allowed us to observe phagocytic vacuoles both in the control
and FLG-treated cells. In FLG-treated cells, we could observe FLG enclosed within these phagocytic
vacuoles (Figure 1C,D, indicated by thick white arrows) and as well as FLG localized in the cytoplasm
(Figure 1C,D, indicated in thin white arrows), likely due to an internalization of the material via
passive diffusion (e.g., FLG sheets below the white dotted box in Figure 1C, near the membrane,
‘sliding through’ cell membrane). The presence of FLG enclosed in large vacuoles (Figure 1E) indicates
instead that the internalization of the material mainly occurs through phagocytosis, a characteristic
of macrophages. Therefore, TEM images captured account for internalization of the FLG partly by
passive diffusion and mainly by phagocytosis. These results are in agreement with previous works.
For instance, Russier et al. showed phagocytic uptake and passive diffusion of GO within human and
murine primary macrophages [24].
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Figure 1. TEM images of BMDMs (bone marrow-derived macrophages). (A) Untreated BMDMs. (B)
Magnified image of a phagocytic vacuole in untreated BMDMs. (C) BMDMs after 24 h incubation
with high-dose FLG (few-layer graphene) (100 µg/mL) showing the nucleus and FLG internalized
within the vacuoles and in the cytoplasm. (D) Magnified image of FLG into a phagocytic vacuole
and into the cytoplasm. (E) Magnified image of phagocytic vacuole (white dotted box in panel (C)
showing internalized FLG in a vacuole. (F) Double-membrane autophagosome with FLG in process
of penetration.
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Autophagosomes, as characterized by double-membrane intracellular organelles which may or
may not engulf particles, were also observed in FLG-treated cells under TEM, but not in the control
untreated cells. These autophagosomes were not seen to physically engulf FLG although it seemed
as if their production was triggered by the presence of material. FLG was also observed to slide into
the autophagosome (Figure 1F), although no successful internalization was seen, unlike with the
phagocytic vacuoles. As such, we decided to conduct further experiments to confirm if there were
significant changes in the possibly relevant autophagic pathway using various assays such as the
measurement of LC3 protein using western blotting.
3.2. Autophagic Activity
Autophagy is a process of degradation of cellular material enclosed by double-membrane
structures called autophagosomes. Autophagosomes eventually fuse with lysosomes to trigger the
degradation of cellular materials [25]. Autophagy is stimulated in cells upon depletion of nutrients
and energy, and it has also been observed upon the encounter of cells with exogenous bodies such as
bacteria, viruses, and nanomaterials [26,27]. The process of autophagy is monitored by the expression of
autophagy-related proteins. Among these proteins, the most commonly used to monitor the autophagic
process is the microtubule-associated light chain 3 (LC3). The conversion of the cytosolic form of
LC3 (LC3-I) into membrane-associated LC3-phosphatidylethanolamine conjugate (LC3-II), which is
recruited by autophagosomal membranes, leading to the induction of autophagic activity, is commonly
used as a marker of autophagy.
A growing body of literature suggests that internalized nanoparticles may undergo autophagic
sequestration. This may lead to autophagy dysfunction and cause cell death, thus playing a key
role in nanoparticle toxicity. To investigate how FLG influences autophagy in primary macrophages,
BMDMs were incubated with low (10 µg/mL) and high (100 µg/mL) doses of graphene for 24 h.
A representative immunoblot (Figure 2A) of cell lysates of untreated, low- and high-dose FLG-treated
and LPS-treated conditions shows the expression of LC3-I and -II with or without lysosomal protease
inhibitors (E64D and pepstatin A). The expression of LC3 proteins in low- and high- dose FLG-treated
cells is similar to basal level as observed in untreated cells and LPS-treated cells [22] and was
observed to be slightly higher in the presence of protease inhibitors, indicating the inhibition of the
degradation of autophagosomes. The visualization of LC3 bands is, however, not enough to attest
to the influence of FLG on autophagic activity induction in macrophages, hence the densitometric
ratio was calculated between membrane-bound LC3-II protein and β-actin (internal loading reference).
From Figure 2B it can be inferred that autophagic activity in the absence of protease inhibitors is slightly
less than all conditions tested in comparison to the presence of protease inhibitors, due to inhibitory
action as mentioned earlier. LPS, which showed no increase in the presence of protease inhibitors,
predictably showed a very slight decrease in autophagic flux, as visualized in Figure 2C, although
there was eventually no significant difference between all conditions. Autophagic flux was calculated
by considering the ratio between the expression of LC3-II in the presence and absence of protease
inhibitors. We can, therefore, deduce that the autophagic activity remains similar to basal level as seen
in untreated cells (Figure 2C). These results are in accordance with cell viability and cellular activation
both in terms of expression of activation molecules and cytokine secretion. Interestingly, the role of
autophagy in the impact of graphene materials has been previously highlighted. Many papers have
already alluded to autophagic dysfunction as a cause of cytotoxicity. Graphene quantum dots, another
member of the graphene family, was reported to cause apoptosis and autophagy in THP-1-derived
macrophages [28]. Di Cristo et al. used FLG dispersed in BSA and investigated autophagic activity in
RAW 264.7 macrophages, where the authors reported an increase in autophagic activity in comparison
to control cells [21]. Here, we used primary macrophages and FLG dispersed in cell culture media,
which is close to the natural physiological environment, reporting an autophagic activity that is
similar to basal level. Our work demonstrates instead that FLG possibly but minimally modulates
autophagic activity.
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activity (LC3-II/β-actin). A One-way ANOVA followed by Bonferroni’s post-test was performed to 
determine the statistical differences for control untreated cells versus FLG-treated samples and LPS-
treated cells (p > 0.05). 
3.3. Cell Viability 
It is equally crucial to know how FLG affects the viability of BMDMs, as macrophages are the 
first line of defenders in innate immunity. Viability was assessed using the viability marker FVD via 
flow cytometry. FVD distinguishes live and dead cells by covalently cross-linking to both extra- and 
intra-cellular proteins of cells with compromised membranes (Figure 3). The viability of BMDMs 
treated with 3, 10, and 30 µg/mL FLG seemed slightly improved compared to untreated control, as 
commonly observed in other experiments in our lab, although without any statistical difference. The 
observed behavior of the cells is consistent with earlier reports where the viability of primary 
embryonic bovine cells treated with rGO and murine macrophage cell line RAW 264.7 treated with 
FLG was not affected [21,29]. We observed increased survival of macrophages treated with 3, 10, and 
30 µg/mL of FLG. This was observed in microscopic images of BMDMs after 24 h interacting with 
FLG, where morphological changes of proliferative cells such as attachment, elongation, and number 
of cell colonies were lower in untreated cells in comparison to FLG- treated cells (Figure S2). Similar 
proliferative behavior has been shown for osteoblastic MC3T3-E1 cells, induced by GO scaffolds [30], 
and in primary human macrophages exposed to pristine graphene and pristine single-walled CNTs, 
which all indicated no loss of viability [31]. Our data show that the viability of BMDMs is not 
detrimentally affected by FLG. This was further confirmed by looking at caspase-3 activity 
identifying apoptotic populations (Figure S3). Interestingly, viability was observed to be slightly 
improved in conditions such as LPS. 
Figure 2. Autophagy analysis in BMDMs after 24 h interaction with FLG. (A) Representative Western
blot of different samples as indicated for LC3 proteins along with internal loading control β-actin
both in the presence (+) and the absence (−) of protease inhibitors E64D and pepstatin A (pepA).
Untreated control (UT) (B) Relative quantification of density ratio of LC3-II to β-actin corresponding
to conditions mentioned earlier. (C) Densitometric evaluation, using ImageJ, of the autophagic flux
considering the ratio between the presence (+) and the absence (−) of E64D/pepA of the autophagic
activity (LC3-II/β-actin). A One-way ANOVA followed by Bonferroni’s post-test was performed
to determine the statistical differences for control untreated cells versus FLG-treated samples and
LPS-treated cells (p > 0.05).
3.3. Cell Viability
It is equally crucial to know how FLG affects the viability of BMDMs, as macrophages are the
first line of defenders in innate immunity. Viability was assessed using the viability marker FVD via
flow cytometry. FVD distinguishes live and dead cells by covalently cross-linking to both extra- and
intra-cellular proteins of cells with compromised membranes (Figure 3). The viability of BMDMs
treated with 3, 10, and 30 µg/mL FLG see ed slightly improved compared to untreated control,
as commonly observed in other experiments in our lab, although without any statistical difference.
The observed behavior of the cells is consistent with earlier reports where the viability of primary
embryonic bovine cells treated with rGO and murine macrophage cell line RAW 264.7 treated with
FLG was not affected [21,29]. We observed increased survival of macrophages treated with 3, 10, and
30 µg/mL of FLG. This was observed in microscopic images of BMDMs after 24 h interacting with FLG,
where morphological changes of proliferative cells such as attachment, elongation, and number of
cell colonies were lower in untreated cells in comparison to FLG- treated cells (Figure S2). Si ilar
proliferative behavior has been shown for osteoblastic MC3T3-E1 cells, induced by GO scaffolds [30],
and in primary human macrophages exposed to pristine graphene and pristine single-walled CNTs,
which all indicated no loss of viability [31]. Our data show that the viability of BMDMs is not
detrimentally affected by FLG. This was further confirmed by looking at caspase-3 activity identifying
apoptotic populations (Figure S3). Interestingly, viability was observed to be slightly improved in
conditions such as LPS.
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3.4. Cell Activation 
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in phagocytosing immune cells such as macrophages. We investigated the upregulation of surface 
activation markers CD80 and CD86 on BMDMs exposed to FLG [32]. CD80 and CD86 expression 
were measured on untreated, FLG-treated and LPS-treated cells (24 h) using flow cytometry (Figure 
4). No statistically significant effect on CD86 expression was observed, though the positive control 
LPS increased CD86 as expected. Treatment with FLG did not affect CD80 expression either, except 
for a small decrease at the highest dose (Figure 4). 
  
Figure 4. Flow cytometry analysis of CD86 (left) and CD80 (right) expression in BMDMs left 
untreated as a control or treated with different concentrations of FLG (3, 10, 30 and 100 µg/mL) or 
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CD86 or CD80 respectively. A One-way ANOVA followed by Bonferroni’s post-test was performed 
to determine the statistical differences for control untreated cells versus FLG-treated samples and 
LPS-treated cells (* p < 0.05). 
3.5. Cytokine Measurement 
Figure 3. Flow cytometry analysis of cellular viability of BMDMs treated with different concentrations
of FLG (3, 10, 30 and 100 µg/mL), with LPS (1 µg/mL) and left untreated, for 24 h. One-way ANOVA
followed by Bonferroni’s test was performed to determine the s atis ical differences among samples
versus control unt eated c lls (* p < 0.05).
3.4. Cell Activation
Cell activation, in turn, is also an important parameter in checking the impact of nanomaterials
in phagocytosing immune cells such as macrophages. We investigated the upregulation of surface
activation markers CD80 and CD86 on BMDMs exposed to FLG [32]. CD80 and CD86 expression
were measured on untreated, FLG-treated and LPS-treated cells (24 h) using flow cytometry (Figure 4).
No statistically significant effect on CD86 expression was observed, though the positive control LPS
increased CD86 as expected. Treatment with FLG did not affect CD80 expression either, except for a
small decrease at the highest dose (Figure 4).
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3.5. Cytokine Measurement 
Figure 4. Flow cytometry analysis of CD86 (left) and CD80 (right) expression in BMDMs left untreated
as a control or treated with different concentrations of FLG (3, 10, 30 and 100 µg/mL) or with LPS
(1 µg/mL), for 24 h. %CD86 and %CD80 refer to the percentage of live gated cells that express CD86 or
CD80 respectively. A One-way ANOVA followed by Bonferroni’s post-test was performed to determine
the statistical differences for control untreated cells versus FLG-treated samples and LPS-treated cells
(* p < 0.05).
3.5. Cytokine Measurement
To further explore the activation profile of the macrophages following their incubation with
different concentrations of FLG (3, 10, 30, and 100 µg/mL) along with untreated and LPS-treated
Nanomaterials 2020, 10, 228 10 of 13
cells, we determined the titers of pro-inflammatory cytokines (IL-6, TNFα, and IL-1β) in the culture
supernatants by ELISA. As shown in Figure 5, IL-6 secretion slightly increases with FLG concentration,
though not significantly when compared to untreated cells. Similarly, secretion of pro-inflammatory
cytokines TNF-α and IL-1β also increases with FLG dose but again there was no significant difference
in cytokine secretion profile. Notably, neutralization or decreased secretion of cytokines has little to
no impact on cell survival, as observed earlier in cell viability assays [33]. The absence of significant
inflammatory cytokine secretion indicates that an inflammatory response in macrophages was not
elicited by FLG.
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Figure 5. Cytokine secretion by BMDMs. (A) IL-6, (B) TNF-α, and (C) IL-1β levels in cell supernatant
after treatment with or without FLG (3, 10, 30, 100 µg/mL), and LPS (1 µg/mL) for 24 h. A One-way
ANOVA followed by Bonferroni’s post-test was performed to determine the statistical differences for
control untreated cells versus FLG-treated samples and LPS-treated cells (* p < 0.05).
4. Conclusions
Our paper provides a closer look, using transmission electron microscopy, at the impact of FLG
on one of the most relevant immune cells involved in uptake and interaction of foreign material – the
macrophage. We subsequently investigated the response of FLG on crucial cellular parameters such as
cytotoxicity, cytokine production, and autophagic processes.
We found that FLG was internalized within the cells through passive diffusion or phagocytosis.
As inflammasome activation is induced by a wide range of stimuli, such as microorganisms,
metabolic dysregulation as well as by nanomaterials [34], phagocytosed FLG was predicted to
evoke inflammasome activity, however, in this study we did not observe any significant increase in
inflammasome-dependant IL-1β production. This was accompanied by no significant secretion of
other pro-inflammatory cytokines such as IL-6 and TNF-α. Altogether, this indicates that FLG did not
evoke inflammatory response in primary bone marrow derived macrophages.
Moreover, this work demonstrates that the viability of primary mouse macrophages was not
affected by FLG after 24 h of incubation. In addition, upregulation of the activation marker CD86 was
not induced in FLG-treated cells, and we even found a slight decrease in CD80 expression. Despite
the control experiments we performed reassure us regarding the validity of our results, we are fully
aware of possible experimental artifacts conducting common assays such as ELISA and flow cytometry
when using FLG and other graphene-related material. Indeed, the material can either increase or
decrease the resultant signal at many stages of sample processing and measurement, thereby affecting
the interpretation of data [35]. Of note, the slight quenching of FVD and other conjugated antibody
fluorescent signal due to FLG, may be circumvented by saturating the amount of dye used.
Finally, the experiments aimed to assess the induction of autophagic activity in primary
macrophages by FLG showed that both low and high doses of FLG did not affect the basal level of
autophagic activity, showing that FLG does not induce any cellular stress.
Overall, our work demonstrates that a short period of interaction of FLG with primary macrophages
does not induce an inflammatory response nor cell toxicity. However, more experiments are required
Nanomaterials 2020, 10, 228 11 of 13
to further investigate the different immunological pathways along with in vitro and in vivo studies to
look at the mechanistic processes towards cellular homeostasis.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4991/10/2/228/s1,
Figure S1. Control experiments for flow cytometry stainings. Control unstained BMDMs are shown in red while
DMSO-treated e780-FVD-stained positive cells (Figure S1A) and CD80-FITC-stained positive cells (Figure S1B)
are shown in blue. Figure S2. Optical microscopy images of untreated, low (10 µg/mL) and high (100 µg/mL)
concentration of FLG and LPS (1 µg/mL)-treated BMDMs for 24 h. Figure S3. Flow cytometry analysis of viability
and apoptosis of BMDMs treated with different concentrations of FLG (3, 10, 30 and 100 µg/mL), with LPS
(1 µg/mL) and left untreated, for 24 h. (A) Representative dot plots, and (B) corresponding bar graph of percentages
of total population of cells showing viable, early apoptotic, late apoptotic and dead population of cells.
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